PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 77 filers reported holding PREVAIL THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $25,910,000 | +126.6% | 1,123,105 | 0.0% | 0.83% | +110.9% |
| Q3 2020 | $11,433,000 | -31.7% | 1,123,105 | 0.0% | 0.40% | -46.3% |
| Q2 2020 | $16,734,000 | +22.2% | 1,123,105 | 0.0% | 0.74% | -21.1% |
| Q1 2020 | $13,691,000 | -23.0% | 1,123,105 | 0.0% | 0.93% | -7.3% |
| Q4 2019 | $17,779,000 | +28.9% | 1,123,105 | 0.0% | 1.01% | +0.6% |
| Q3 2019 | $13,792,000 | -7.0% | 1,123,105 | 0.0% | 1.00% | -21.6% |
| Q2 2019 | $14,825,000 | – | 1,123,105 | – | 1.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|